Aaron Kellogg, Ph.D. - Publications
Affiliations: | 2008 | The University of Toledo |
Area:
Medicine and Surgery, Neuroscience BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2013 | Gualeni B, Rajpar MH, Kellogg A, Bell PA, Arvan P, Boot-Handford RP, Briggs MD. A novel transgenic mouse model of growth plate dysplasia reveals that decreased chondrocyte proliferation due to chronic ER stress is a key factor in reduced bone growth. Disease Models & Mechanisms. 6: 1414-25. PMID 24046357 DOI: 10.1242/Dmm.013342 | 0.307 | |||
2009 | Pop-Busui R, Oral E, Raffel D, Byun J, Bajirovic V, Vivekanandan-Giri A, Kellogg A, Pennathur S, Stevens MJ. Impact of rosiglitazone and glyburide on nitrosative stress and myocardial blood flow regulation in type 2 diabetes mellitus. Metabolism: Clinical and Experimental. 58: 989-94. PMID 19394661 DOI: 10.1016/J.Metabol.2009.02.020 | 0.525 | |||
2009 | Kellogg AP, Converso K, Wiggin T, Stevens M, Pop-Busui R. Effects of cyclooxygenase-2 gene inactivation on cardiac autonomic and left ventricular function in experimental diabetes. American Journal of Physiology. Heart and Circulatory Physiology. 296: H453-61. PMID 19060127 DOI: 10.1152/Ajpheart.00678.2008 | 0.611 | |||
2008 | Kellogg AP, Cheng HT, Pop-Busui R. Cyclooxygenase-2 pathway as a potential therapeutic target in diabetic peripheral neuropathy. Current Drug Targets. 9: 68-76. PMID 18220714 DOI: 10.2174/138945008783431691 | 0.596 | |||
2007 | Kellogg AP, Wiggin TD, Larkin DD, Hayes JM, Stevens MJ, Pop-Busui R. Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes. Diabetes. 56: 2997-3005. PMID 17720896 DOI: 10.2337/Db07-0740 | 0.591 | |||
2005 | Kellogg AP, Pop-Busui R. Peripheral nerve dysfunction in experimental diabetes is mediated by cyclooxygenase-2 and oxidative stress. Antioxidants & Redox Signaling. 7: 1521-9. PMID 16356116 DOI: 10.1089/Ars.2005.7.1521 | 0.629 | |||
Show low-probability matches. |